Some of the deals completed in 2009 include:
Cariescan raises £750,000 in funds
Cariescan, the dental technology group formed out of university spinout, IDMOS, has raised £750,000, its second fundraising this year. The Dundee based company said the cash, raised from existing shreholders including Scottish Enterprise, would be used for research and marketing investment.
Chief Executive Graham Lay said Cariescan's first product, which it claims measures tooth decay more accurately than X-Rays, is now on sale in the UK, while a distribution agreement for Canada is imminent.
November 2009
PowerPhotonic builds production and sales
Co-ordinated by DC Consulting’s John Craig, PowerPhotonic has recently been awarded a £80,000 RSA award to support a ramp up in production and sales activity. This grant award augments a £325,000 investment into the company led by Archangel Informal Investments and Tri Capital.
J Funerals Limited - SEED Investment
In a transaction co-ordinated by John Craig, J Funerals Limited have successfully completed the SEED investment to launch its products in the funeral market place.This investment brings together Sandra Thomson, who has worked in the Jute Industry since 1985 (and widely accepted as an expert in this field), and David McKenzie, previous founder and CEO of Commsworld Limited with the primary aim of delivery eco-friendly coffins and associated funereal products to the mainstream market.J funerals™ coffins, coffin accessories, urns and other accessories are made from the natural silky fibres of jute, which is an eco-friendly crop grown for generations in the Ganges Delta.
Novabiotics Limited - Equity £1.1m
The DC Consulting team, led by Angus Hay, has successfully assisted NovaBiotics Limited in securing an equity investment of £1.1 million. The investment was made by both existing shareholders in the company and by new sources of funds introduced by DC Consulting, including Discovery Investment Fund, TRIcap and Aurora Private Equity. After the successful completion of the transaction, NovaBiotics announced regulatory and ethics clearance had been obtained to commence clinical trials of its lead product Novexatin.
CarieScan Limited - Equity £2m
Graham Lay pays particular tribute to the role that DC’s Alison Williamson played in securing £2m of equity for CarieScan. CarieScan, based in Dundee, is taking to market a device which uses AC impedance spectroscopy (ACIST) to determine the mineral density of dental substrate, as a means of detecting tooth decay at an earlier stage than usual, and monitoring its progress accurately.
Ciqual Limited - Equity £1.25m
Headed up by John Craig, DC Consulting has successfully assisted the management team of Ciqual Limited in securing equity investment of £1.25m. The investment was financed by a consortium headed by the Par Syndicate and Scottish Enterprise’s Scottish Co-investment Fund. CIQUAL will use the investment to accelerate product development and sales of its Session Insight System into the mobile broadband market.
Read the full story at www.ciqual.com/ciqual-secures-funding.php
Centeo Biosciences Limited - Equity Package of £700,000
In a deal that was co-ordinated by Angus Hay & Nina Ledlie, DC Consulting has successfully concluded the equity funding package of £700,000 for Centeo Biosciences Limited. The investment was led by Highland Venture Capital, the Inverness-based business angel syndicate, with support from TRI Cap business angels, LINC Scotland, Upstarts Syndicate and Scottish Enterprise's Co-Investment Fund.
Centeo has designed the market's only hand-held portable thermal control unit, allowing test samples to be exposed to multiple, controlled temperatures, saving time and increasing the accuracy of testing.
Read the full story at: www.centeo.com